Menu Close

Articles on Antibodies

Displaying 21 - 40 of 108 articles

The omicron variant possesses numerous mutations in the spike protein, the knob-like protrusions (in red) that allow the virus to invade other cells. Juan Gaertner/Science Photo Library via Getty Images

Will omicron – the new coronavirus variant of concern – be more contagious than delta? A virus evolution expert explains what researchers know and what they don’t

It’s too early to say whether the newly identified omicron variant is going to overtake delta. But particular mutations in the new strain have researchers deeply concerned.
Pregnancy poses significant risks for severe illness or death from COVID-19, for both mother and baby. ArtMarie/E+ via Getty Images

Vaccination against COVID-19 supports a healthy pregnancy by protecting both mother and child – an immunologist explains the maternal immune response

In light of mounting research showing the serious risks of contracting COVID-19 during pregnancy, the CDC is re-upping its urgency that pregnant women get their shots.
Public health officials have been waiting for good data before making any decisions about booster shots for people who received Johnson & Johnson’s Janssen COVID-19 vaccine. AP Photo/Mary Altaffer

New Johnson & Johnson data shows second shot boosts antibodies and protection against COVID-19 – but one dose is still strong against delta variant

Your body produces antibodies after an infection or vaccine, but these slowly decline over time. New Johnson & Johnson data sheds light on the duration of protection and the need for booster shots.
People getting vaccinated may still have questions about COVID-19 vaccines, like why it takes two doses — and then two weeks — to take full effect. THE CANADIAN PRESS/Ryan Remiorz

I work at a COVID-19 vaccine clinic. Here’s what people ask me when they’re getting their shot — and what I tell them

A medical student answers questions he gets asked at a COVID-19 vaccine clinic: Efficacy versus real-world effectiveness, immune response and how the mRNA vaccines compare to vaccines already in wide use.
By better communicating how vaccines boost the immune system’s long term “memory”, manufacturers could address vaccine hesitancy. i_am_zews/Shutterstock

COVID-19 vaccines produce T-cell immunity that lasts and works against virus variants

Cell-mediated immunity is particularly effective at eradicating viruses, and more durable. This is important in the fight against COVID-19.
A little more than 8% of vaccinated people in the U.S. have received the Johnson & Johnson vaccine. SOPA Images/Contributor/Light Rocket via Getty Images

Do I need a booster shot if I got the Johnson & Johnson vaccine? A virologist answers 5 questions

It has been six months since the Johnson & Johnson vaccine received emergency use authorization. What does six months of data show about its efficacy, side effects and protection from variants?

Top contributors

More